Nikhil Lalwani
2021
In 2021, Nikhil Lalwani earned a total compensation of $6.5M as President and Chief Executive Officer at ANI Pharmaceuticals, a 76% increase compared to previous year.
Compensation breakdown
| Bonus | $1,442,000 |
|---|---|
| Salary | $715,347 |
| Stock Awards | $4,369,205 |
| Other | $14,508 |
| Total | $6,541,060 |
Lalwani received $4.4M in stock awards, accounting for 67% of the total pay in 2021.
Lalwani also received $1.4M in bonus, $715.3K in salary and $14.5K in other compensation.
Rankings
In 2021, Nikhil Lalwani's compensation ranked 1,907th out of 12,415 executives tracked by ExecPay. In other words, Lalwani earned more than 84.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,907 out of 12,415 | 85th |
Division Manufacturing | 718 out of 5,505 | 87th |
Major group Chemicals And Allied Products | 272 out of 2,375 | 89th |
Industry group Drugs | 232 out of 2,096 | 89th |
Industry Pharmaceutical Preparations | 156 out of 1,546 | 90th |
Pay ratio
| Nikhil Lalwani's Pay | $6,541,060 |
|---|---|
| Median Employee's Pay | $50,403 |
| Pay Ratio | 130to 1 |
In 2021, the annual total compensation of Nikhil Lalwani was $6,541,060.
The annual total compensation of the median employee at ANI Pharmaceuticals was $50,403.
The ratio of Nikhil Lalwani's pay to the pay of median employee was therefore 130 to one.
Source: SEC filing on March 25, 2022.
Lalwani's colleagues
We found four more compensation records of executives who worked with Nikhil Lalwani at ANI Pharmaceuticals in 2021.